The study evaluated the absorption, distribution, and excretion of SPC-15 over a 7-day period, with peak drug concentrations occurring between 0.5 and 2 hours after intranasal administration, in ...
Silo Pharma, Inc. announced a service agreement with Resyca BV to conduct a drug-device study on its microchip-based nasal spray system for SPC-15, an intranasal treatment for PTSD. This study aims to ...
The study evaluated the absorption, distribution, and excretion of SPC-15 over a 7-day period, with peak drug concentrations occurring between 0.5 and 2 hours after intranasal administration, in ...
The final drug studies are 1) an investigational new drug (IND)-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetic animal study, and 2) a U.S. Food and Drug Administration ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile